UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sevelamer (694) 694
humans (612) 612
science & technology (546) 546
life sciences & biomedicine (540) 540
urology & nephrology (376) 376
male (318) 318
female (307) 307
polyamines - therapeutic use (282) 282
middle aged (255) 255
chelating agents - therapeutic use (229) 229
renal dialysis (198) 198
aged (189) 189
hyperphosphatemia (163) 163
kidney failure, chronic - therapy (151) 151
kidney failure, chronic - complications (150) 150
adult (141) 141
hyperphosphatemia - drug therapy (140) 140
calcium - blood (134) 134
sevelamer hydrochloride (133) 133
phosphates - blood (130) 130
hemodialysis (126) 126
polyamines (126) 126
phosphorus - blood (124) 124
treatment outcome (121) 121
parathyroid hormone - blood (108) 108
nephrology (104) 104
phosphates (102) 102
renal dialysis - adverse effects (102) 102
chronic kidney disease (98) 98
hyperphosphatemia - etiology (95) 95
animals (93) 93
polyamines - administration & dosage (92) 92
sevelamer carbonate (91) 91
phosphates - metabolism (86) 86
phosphate binders (85) 85
lanthanum - therapeutic use (84) 84
epoxy compounds - therapeutic use (79) 79
polyethylenes - therapeutic use (79) 79
calcium carbonate - therapeutic use (78) 78
chronic kidney failure (76) 76
calcium (75) 75
calcinosis - etiology (71) 71
phosphate binder (71) 71
calcium carbonate (70) 70
kidney failure, chronic - blood (69) 69
kidney failure, chronic - drug therapy (69) 69
pharmacology & pharmacy (68) 68
polyamines - pharmacology (67) 67
dialysis (66) 66
kidney diseases (66) 66
prospective studies (66) 66
transplantation (64) 64
polyamines - adverse effects (62) 62
chelating agents - adverse effects (61) 61
phosphorus (59) 59
chelating agents - administration & dosage (57) 57
chelating agents - pharmacology (57) 57
mortality (57) 57
chronic disease (56) 56
phosphate (56) 56
parathyroid hormone (55) 55
time factors (55) 55
risk factors (54) 54
lanthanum carbonate (53) 53
renal insufficiency, chronic - complications (53) 53
calcium compounds - therapeutic use (52) 52
hyperparathyroidism, secondary - etiology (52) 52
lanthanum (51) 51
sevelamer - therapeutic use (50) 50
acetates - therapeutic use (49) 49
calcinosis - prevention & control (49) 49
calcium - metabolism (48) 48
vascular calcification (48) 48
aged, 80 and over (43) 43
hematology (43) 43
biomarkers - blood (42) 42
care and treatment (42) 42
drug therapy, combination (42) 42
analysis (41) 41
medicine & public health (40) 40
follow-up studies (39) 39
hyperparathyroidism, secondary - drug therapy (39) 39
kidney diseases - complications (39) 39
renal insufficiency, chronic - drug therapy (39) 39
calcification (38) 38
kidney failure, chronic - metabolism (37) 37
carbonates (36) 36
end-stage renal disease (36) 36
hyperphosphatemia - blood (36) 36
renal dialysis - methods (36) 36
cardiovascular diseases - etiology (35) 35
randomized controlled trials as topic (35) 35
rats (35) 35
medical research (34) 34
disease progression (33) 33
health aspects (33) 33
phosphorus metabolism disorders - drug therapy (33) 33
practice guidelines as topic (33) 33
calcinosis - drug therapy (32) 32
phosphorus metabolism disorders - etiology (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (793) 793
Japanese (63) 63
Spanish (26) 26
French (14) 14
German (10) 10
Polish (6) 6
Italian (3) 3
Portuguese (3) 3
Russian (2) 2
Czech (1) 1
Dutch (1) 1
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Indian Journal of Nephrology, ISSN 0971-4065, 5/2019, Volume 29, Issue 3, pp. 191 - 193
Journal Article
BioMed research international, ISSN 2314-6133, 6/2015, Volume 2015, pp. 515606 - 9
Journal Article
Clinical journal of the American Society of Nephrology, ISSN 1555-9041, 09/2017, Volume 12, Issue 9, pp. 1489 - 1497
Journal Article
PharmacoEconomics, ISSN 1170-7690, 12/2015, Volume 33, Issue 12, pp. 1311 - 1324
Journal Article
Revista española de patología, ISSN 1699-8855, 10/2015, Volume 48, Issue 4, pp. 250 - 254
Sevelamer is a non-absorbable phosphate binder used to treat hyperphosphatemia in patients with chronic renal disease. Sevelamer morphology has been described... 
Sevelamer chlorhydrate | Kayexalate | Sevelamer carbonate | Crystal
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 11/2014, Volume 210, Issue 10, pp. 1549 - 1554
Journal Article
Journal Article
Journal Article